Suppr超能文献

鉴定DNA甲基转移酶3a作为T细胞受体诱导的Th1和Th2分化调节因子。

Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation.

作者信息

Gamper Christopher J, Agoston Agoston T, Nelson William G, Powell Jonathan D

机构信息

Department of Oncology, Johns Hopkins University, School of Medicine, Baltimore, MD 21231, USA.

出版信息

J Immunol. 2009 Aug 15;183(4):2267-76. doi: 10.4049/jimmunol.0802960. Epub 2009 Jul 22.

Abstract

Ag-specific T cell cytokine expression is dictated by the context in which TCR engagement occurs. Recently it has become clear that epigenetic changes play a role in this process. DNA methyltransferase 3a (DNMT3a) is a de novo methyltransferase important to the epigenetic control of cell fate. We have determined that DNMT3a expression is increased following TCR engagement and that costimulation mitigates DNMT3a protein expression. T cells lacking DNMT3a simultaneously express IFN-gamma and IL-4 after expansion under nonbiasing conditions. While global methylation of DNA from wild-type and knockout T cells is similar, DNMT3a-null T cells demonstrate selective hypomethylation of both the Il4 and Ifng loci after activation. Such hypomethylated knockout Th2 cells retain a greater capacity to express IFN-gamma protein when they are subsequently exposed to Th1-biasing conditions. Based on these findings we propose that DNMT3a is a key participant in regulating T cell polarization at the molecular level by promoting stable selection of a context-specific cell fate through methylation of selective targets in T cells.

摘要

抗原特异性T细胞细胞因子的表达取决于TCR参与的背景。最近已经明确,表观遗传变化在这一过程中发挥作用。DNA甲基转移酶3a(DNMT3a)是一种对细胞命运的表观遗传控制很重要的从头甲基转移酶。我们已经确定,TCR参与后DNMT3a的表达会增加,并且共刺激会减轻DNMT3a蛋白的表达。在无偏向条件下扩增后,缺乏DNMT3a的T细胞同时表达IFN-γ和IL-4。虽然野生型和基因敲除T细胞的DNA整体甲基化情况相似,但DNMT3a基因敲除的T细胞在激活后显示Il4和Ifng基因座均发生选择性低甲基化。当这些低甲基化的基因敲除Th2细胞随后暴露于Th1偏向条件时,它们保留了更大的表达IFN-γ蛋白的能力。基于这些发现,我们提出DNMT3a是通过对T细胞中的选择性靶标进行甲基化来促进特定背景细胞命运的稳定选择,从而在分子水平上调节T细胞极化的关键参与者。

相似文献

1
Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation.
J Immunol. 2009 Aug 15;183(4):2267-76. doi: 10.4049/jimmunol.0802960. Epub 2009 Jul 22.
2
Altered Th1 cell differentiation programming by CIITA deficiency.
J Immunol. 2004 Nov 1;173(9):5501-8. doi: 10.4049/jimmunol.173.9.5501.
4
DNA methylation is a nonredundant repressor of the Th2 effector program.
J Immunol. 2004 Oct 1;173(7):4402-6. doi: 10.4049/jimmunol.173.7.4402.
8
Cutting edge: Ikaros is a regulator of Th2 cell differentiation.
J Immunol. 2009 Jan 15;182(2):741-5. doi: 10.4049/jimmunol.182.2.741.
9
Selective expression rather than specific function of Txk and Itk regulate Th1 and Th2 responses.
J Immunol. 2008 Nov 1;181(9):6125-31. doi: 10.4049/jimmunol.181.9.6125.

引用本文的文献

1
Clonal hematopoiesis of indeterminate potential and risk of autoimmune thyroid disease.
BMC Med. 2025 Apr 23;23(1):237. doi: 10.1186/s12916-025-04077-z.
2
Supercharging CAR-T cells through transcriptional and epigenetic armoring.
Theranostics. 2025 Feb 18;15(8):3345-3367. doi: 10.7150/thno.107908. eCollection 2025.
4
Dysregulation of epigenetic modifications in inborn errors of immunity.
Epigenomics. 2024;16(19-20):1301-1313. doi: 10.1080/17501911.2024.2410695. Epub 2024 Oct 15.
5
Methylation of T and B Lymphocytes in Autoimmune Rheumatic Diseases.
Clin Rev Allergy Immunol. 2024 Jun;66(3):401-422. doi: 10.1007/s12016-024-09003-4. Epub 2024 Aug 29.
7
The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases.
Adv Exp Med Biol. 2023;1442:65-83. doi: 10.1007/978-981-99-7471-9_5.
8
Evaluation of Clinical and Immunological Alterations Associated with ICF Syndrome.
J Clin Immunol. 2023 Dec 22;44(1):26. doi: 10.1007/s10875-023-01620-6.
9
The impact of epigenetic modifications on allogeneic hematopoietic stem cell transplantation.
Front Immunol. 2023 May 31;14:1188853. doi: 10.3389/fimmu.2023.1188853. eCollection 2023.
10
Clonal haematopoiesis and dysregulation of the immune system.
Nat Rev Immunol. 2023 Sep;23(9):595-610. doi: 10.1038/s41577-023-00843-3. Epub 2023 Mar 20.

本文引用的文献

2
Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus.
Br J Dermatol. 2008 Sep;159(4):827-33. doi: 10.1111/j.1365-2133.2008.08758.x. Epub 2008 Jul 17.
4
Cyclical DNA methylation of a transcriptionally active promoter.
Nature. 2008 Mar 6;452(7183):45-50. doi: 10.1038/nature06544.
5
Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus.
Immunology. 2008 Jul;124(3):339-47. doi: 10.1111/j.1365-2567.2007.02771.x. Epub 2008 Jan 11.
6
Demethylation of a specific hypersensitive site in the Th2 locus control region.
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17052-7. doi: 10.1073/pnas.0708293104. Epub 2007 Oct 12.
7
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15805-10. doi: 10.1073/pnas.0707628104. Epub 2007 Sep 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验